Skip to content
lifestyle.cleanweb.co
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Absci Corporation
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
September 24, 2026
Absci to Participate in Upcoming Investor Conferences
September 1, 2026
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 12, 2026
Absci to Participate in Upcoming Investor Conferences
May 20, 2026
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
May 8, 2026
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
May 4, 2026
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference
May 2, 2026
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
March 28, 2026
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
March 28, 2026